Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Rank	Δ	Cancer	Trial Gap Index (percentile points)	Percentile	Confidence	Sources	Why #n?
1	▲1	Malignant Colon Neoplasm	+51.9	100	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 19909 formula percentile(mortality_count) − percentile(active_trials) activity 225 burdenPercentile 88.9 activityPercentile 37 ranking row 2603205
2	▲1	Malignant Vulvar Neoplasm	+25.9	96.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 1316 formula percentile(mortality_count) − percentile(active_trials) activity 54 burdenPercentile 33.3 activityPercentile 7.4 ranking row 2603206
3	▲3	Malignant Uterine Corpus Neoplasm	+14.8	92.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 6416 formula percentile(mortality_count) − percentile(active_trials) activity 411 burdenPercentile 66.7 activityPercentile 51.9 ranking row 2603207
4	=	Cutaneous Melanoma	+14.8	88.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 2904 formula percentile(mortality_count) − percentile(active_trials) activity 78 burdenPercentile 37 activityPercentile 22.2 ranking row 2603208
5	▲1	Malignant Ovarian Neoplasm	+14.8	85.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 13748 formula percentile(mortality_count) − percentile(active_trials) activity 684 burdenPercentile 85.2 activityPercentile 70.4 ranking row 2603209
6	▲2	Malignant Bladder Neoplasm	+11.2	81.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4663 formula percentile(mortality_count) − percentile(active_trials) activity 346 burdenPercentile 55.6 activityPercentile 44.4 ranking row 2603210
7	▼2	Malignant Vaginal Neoplasm	+11.1	77.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 392 formula percentile(mortality_count) − percentile(active_trials) activity 31 burdenPercentile 11.1 activityPercentile 0 ranking row 2603211
8	▲1	Malignant Laryngeal Neoplasm	+11.1	74.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 761 formula percentile(mortality_count) − percentile(active_trials) activity 66 burdenPercentile 25.9 activityPercentile 14.8 ranking row 2603212
9	▲1	Malignant Pancreatic Neoplasm	+11.1	70.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 21737 formula percentile(mortality_count) − percentile(active_trials) activity 904 burdenPercentile 92.6 activityPercentile 81.5 ranking row 2603213
10	▲4	Malignant Anal Neoplasm	+3.7	66.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 737 formula percentile(mortality_count) − percentile(active_trials) activity 68 burdenPercentile 22.2 activityPercentile 18.5 ranking row 2603214
11	▲4	Malignant Kidney Neoplasm	+3.7	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4946 formula percentile(mortality_count) − percentile(active_trials) activity 453 burdenPercentile 59.3 activityPercentile 55.6 ranking row 2603215
12	▲5	Malignant Breast Neoplasm	0	59.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 42465 formula percentile(mortality_count) − percentile(active_trials) activity 2627 burdenPercentile 96.3 activityPercentile 96.3 ranking row 2603216
12	▲5	Malignant Lung Neoplasm	0	59.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 65847 formula percentile(mortality_count) − percentile(active_trials) activity 2644 burdenPercentile 100 activityPercentile 100 ranking row 2603217
12	▲4	Malignant Rectal Neoplasm	0	59.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4290 formula percentile(mortality_count) − percentile(active_trials) activity 386 burdenPercentile 48.1 activityPercentile 48.1 ranking row 2603219
12	▲16	Malignant Thyroid Gland Neoplasm	0	59.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 1106 formula percentile(mortality_count) − percentile(active_trials) activity 176 burdenPercentile 29.6 activityPercentile 29.6 ranking row 2603218
16	▲5	Malignant Salivary Gland Neoplasm	-3.7	44.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 386 formula percentile(mortality_count) − percentile(active_trials) activity 63 burdenPercentile 7.4 activityPercentile 11.1 ranking row 2603220
17	▲5	Malignant Hypopharyngeal Neoplasm	-3.7	40.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 91 formula percentile(mortality_count) − percentile(active_trials) activity 53 burdenPercentile 0 activityPercentile 3.7 ranking row 2603221
18	▲5	Malignant Central Nervous System Neoplasm	-7.4	37	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 7395 formula percentile(mortality_count) − percentile(active_trials) activity 823 burdenPercentile 70.4 activityPercentile 77.8 ranking row 2603222
19	=	Malignant Mesothelioma	-7.4	33.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 562 formula percentile(mortality_count) − percentile(active_trials) activity 96 burdenPercentile 18.5 activityPercentile 25.9 ranking row 2603223
20	▲7	Leukemia	-7.4	29.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9771 formula percentile(mortality_count) − percentile(active_trials) activity 1769 burdenPercentile 81.5 activityPercentile 88.9 ranking row 2603224
20	▼1	Malignant Liver Neoplasm	-7.4	29.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9092 formula percentile(mortality_count) − percentile(active_trials) activity 906 burdenPercentile 77.8 activityPercentile 85.2 ranking row 2603225
22	▲2	Multiple Myeloma	-11.1	22.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5562 formula percentile(mortality_count) − percentile(active_trials) activity 814 burdenPercentile 63 activityPercentile 74.1 ranking row 2603226
23	▲6	Malignant Gastric Neoplasm	-14.8	18.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4415 formula percentile(mortality_count) − percentile(active_trials) activity 652 burdenPercentile 51.9 activityPercentile 66.7 ranking row 2603227
24	▲6	Malignant Cervical Neoplasm	-14.9	14.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4138 formula percentile(mortality_count) − percentile(active_trials) activity 505 burdenPercentile 44.4 activityPercentile 59.3 ranking row 2603228
25	▲9	Hodgkin Lymphoma	-18.5	11.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 424 formula percentile(mortality_count) − percentile(active_trials) activity 179 burdenPercentile 14.8 activityPercentile 33.3 ranking row 2603229
26	▲6	Non-Hodgkin Lymphoma	-18.5	7.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 8609 formula percentile(mortality_count) − percentile(active_trials) activity 2168 burdenPercentile 74.1 activityPercentile 92.6 ranking row 2603230
27	▲5	Malignant Esophageal Neoplasm	-22.3	3.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3122 formula percentile(mortality_count) − percentile(active_trials) activity 518 burdenPercentile 40.7 activityPercentile 63 ranking row 2603231
28	▲7	Malignant Nasopharyngeal Neoplasm	-37	0	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 171 formula percentile(mortality_count) − percentile(active_trials) activity 261 burdenPercentile 3.7 activityPercentile 40.7 ranking row 2603232

Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash 0fa5b9e268b1357f90e26f38

Methodology

How this table was built

Formula: percentile(mortality_count) − percentile(active_trials)
Version: ci-trial-gap-v1
Scope: USA · Female · all ages · 2018 · top-level cancers
Scope key: geo=USA|sex=female|age=all|year=2018|level=top
Eligible entities: 28
Generated: Sep 29, 2026, 06:30 AM UTC
Inputs hash: 0fa5b9e268b1357f90e26f38
Sources: U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality clinicaltrials cdc-wonder seer iarc-globocan
Aggregation: none

Eligibility

requires: mortality_count
active_trials
entityLevel: top

Full methodology · ties share a rank (1, 2, 2, 4) · previous rank refers to the last snapshot of the same scope.

Download CSV (with attribution)

Burden and lethality metrics depend on registry definitions (site groups, standard population, estimate type). Compare only within one table.